Skip to main content
logo
Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
1.660
+0.010 (0.61%)
Sep 4, 2026, 12:08 PM EDT - Market open

Alaunos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
47317155234
Market Cap Growth
-15.66%136.33%-82.04%-89.08%-33.56%-56.40%
Enterprise Value
4516143172
Last Close Price
1.653.231.9110.6097.36163.50

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
1397.261441.76305.043396.2853.20587.82
PB Ratio
6.293.351.482.694.034.03
P/TBV Ratio
6.433.351.482.694.034.03

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
1355.931054.16136.741241.6849.00431.80

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
----0.510.51
Net Debt / Equity Ratio
-0.19-0.64-0.53-0.96-0.51-0.80
Net Debt / EBITDA Ratio
0.030.330.230.230.650.66
Net Debt / FCF Ratio
0.040.470.220.200.660.72
Asset Turnover
0.000.000.0000.040.00
Quick Ratio
0.141.711.583.101.624.81
Current Ratio
0.772.443.984.222.234.91
Return on Equity (ROE)
-185.95%-198.10%-111.80%-156.66%-78.11%-86.52%
Return on Assets (ROA)
-81.13%-92.31%-54.59%-48.66%-25.61%-37.91%
Return on Capital Employed (ROCE)
-622.20%-196.20%-233.30%-451.80%-80.30%-92.80%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-98.19%-57.93%-153.39%-206.93%-24.27%-33.66%
FCF Yield
-67.39%-41.16%-162.96%-178.66%-18.95%-27.69%
Buyback Yield / Dilution
-43.66%-21.68%-0.11%-10.50%-1.27%-2.27%
SEC Filings: 10-K · 10-Q